KMT2D and melanoma: We found loss of MLL3 and MLL4 completely abolishes the metastatic potential of melanoma cells when intravenously injected into immunocompetent mice (Supplementary Fig. 2i), indicating potential involvement of immune response for inhibition of melanoma metastasis and colonization as well.